Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Mouse VEGFR-2 Antibody (DC101) is a rat-derived monoclonal antibody against mouse VEGFR2/KDR/Flk-1, serving as a mouse analogue of ramucirumab. It induces tumour cell apoptosis by blocking VEGF-VEGFR binding and inhibiting tumour angiogenesis, suitable for studying colorectal and gastric cancers.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $73 | 2-4 weeks | 2-4 weeks | |
| 5 mg | Preferential | - | In Stock | |
| 10 mg | Preferential | 2-4 weeks | 2-4 weeks |
| Description | Anti-Mouse VEGFR-2 Antibody (DC101) is a rat-derived monoclonal antibody against mouse VEGFR2/KDR/Flk-1, serving as a mouse analogue of ramucirumab. It induces tumour cell apoptosis by blocking VEGF-VEGFR binding and inhibiting tumour angiogenesis, suitable for studying colorectal and gastric cancers. |
| In vivo | Methods: Anti-Mouse VEGFR-2 Antibody (DC101) (10 mg/kg, administered on days 2, 5, and 8) was injected intraperitoneally into female Balb/c mice bearing H22 tumors. Results: Anti-Mouse VEGFR-2 Antibody (DC101) promoted tumor vascular normalization, improved tumor vascular perfusion, reduced hypoxic regions, and increased the number of CD8+ T cells within the tumor.[1] |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.